These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20123018)

  • 1. HDAC inhibitors and neurodegeneration: at the edge between protection and damage.
    Dietz KC; Casaccia P
    Pharmacol Res; 2010 Jul; 62(1):11-7. PubMed ID: 20123018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
    D'Mello SR
    Drug News Perspect; 2009 Nov; 22(9):513-24. PubMed ID: 20072728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple roles of HDAC inhibition in neurodegenerative conditions.
    Chuang DM; Leng Y; Marinova Z; Kim HJ; Chiu CT
    Trends Neurosci; 2009 Nov; 32(11):591-601. PubMed ID: 19775759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
    Ziemka-Nalecz M; Jaworska J; Sypecka J; Zalewska T
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):855-870. PubMed ID: 30165682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management.
    Ye L; Li W; Tang X; Xu T; Wang G
    Curr Neuropharmacol; 2024; 22(14):2298-2313. PubMed ID: 38288835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of naturally occurring histone deacetylase inhibitors.
    Kim B; Hong J
    Curr Top Med Chem; 2015; 14(24):2759-82. PubMed ID: 25487010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.
    Gupta R; Ambasta RK; Kumar P
    Life Sci; 2020 Feb; 243():117278. PubMed ID: 31926248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.
    Sharma S; Sarathlal KC; Taliyan R
    CNS Neurol Disord Drug Targets; 2019; 18(1):11-18. PubMed ID: 30289079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone acetylation for neuroprotection.
    Contestabile A
    Curr Pharm Des; 2013; 19(28):5017-8. PubMed ID: 23448467
    [No Abstract]   [Full Text] [Related]  

  • 11. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G; Jiang H; Chang M; Xie H; Hu L
    J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.
    Trüe O; Matthias P
    Immunol Cell Biol; 2012 Jan; 90(1):78-84. PubMed ID: 22124372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.
    Saha RN; Pahan K
    Cell Death Differ; 2006 Apr; 13(4):539-50. PubMed ID: 16167067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic application of histone deacetylase inhibitors for stroke.
    Lv L; Tang YP; Han X; Wang X; Dong Q
    Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):138-49. PubMed ID: 21521169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylases: focus on the nervous system.
    Morrison BE; Majdzadeh N; D'Mello SR
    Cell Mol Life Sci; 2007 Sep; 64(17):2258-69. PubMed ID: 17530170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
    Hyndman KA
    Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylases in memory and cognition.
    Penney J; Tsai LH
    Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
    Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
    Expert Opin Investig Drugs; 2007 May; 16(5):569-71. PubMed ID: 17461732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation.
    Gaub P; Tedeschi A; Puttagunta R; Nguyen T; Schmandke A; Di Giovanni S
    Cell Death Differ; 2010 Sep; 17(9):1392-408. PubMed ID: 20094059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.